BiotechTube
Home/Renovion/Dan Copeland
DC

Dan Copeland

Chief Executive Officer

Renovion

Therapeutic Areas

PulmonologyTransplant Medicine

Renovion Pipeline

DrugIndicationPhase
ARINA-1 (RVN-301)Non-Cystic Fibrosis Bronchiectasis (NCFBE)Phase 2

Leadership Team at Renovion

CD
Carolyn Durham, PhD
Chief Scientific Officer
MZ
Marty Zamora, MD
Chief Medical Officer
MT
Marilyn Thompson
Head of Finance
HC
Hal Craig
Head of Chemistry, Manufacturing, and Controls Strategy and Operations
DW
Derek Winstanly, MBChB
Chairman of the Board
View full Renovion profile